160 related articles for article (PubMed ID: 31478429)
1. Granuloma-like lesion at subcutaneous immunoglobulin site in a common variable immunodeficiency patient.
Gupta A; Wang B; Gupta S
Immunotherapy; 2019 Oct; 11(14):1177-1180. PubMed ID: 31478429
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin (IVIG) efficiency in women with common variable immunodeficiency (CVID) decreases significantly during pregnancy.
Egawa M; Kanegane H; Imai K; Morio T; Miyasaka N
J Matern Fetal Neonatal Med; 2019 Sep; 32(18):3092-3096. PubMed ID: 29614902
[TBL] [Abstract][Full Text] [Related]
3. Renal granuloma and immunoglobulin M-complex glomerulonephritis: a case of common variable immunodeficiency?
Benoit G; Lapeyraque AL; Sartelet H; Saint-Cyr C; Le Deist F; Haddad E
Pediatr Nephrol; 2009 Mar; 24(3):601-4. PubMed ID: 18696117
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous immunoglobulin replacement therapy for primary antibody deficiency: advancements into the 21st century.
Moore ML; Quinn JM
Ann Allergy Asthma Immunol; 2008 Aug; 101(2):114-21; quiz 122-3, 178. PubMed ID: 18727465
[TBL] [Abstract][Full Text] [Related]
5. The Natural History of Untreated Primary Hypogammaglobulinemia in Adults: Implications for the Diagnosis and Treatment of Common Variable Immunodeficiency Disorders (CVID).
Ameratunga R; Ahn Y; Steele R; Woon ST
Front Immunol; 2019; 10():1541. PubMed ID: 31379811
[No Abstract] [Full Text] [Related]
6. New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin.
Ameratunga R; Woon ST; Gillis D; Koopmans W; Steele R
Clin Exp Immunol; 2013 Nov; 174(2):203-11. PubMed ID: 23859429
[TBL] [Abstract][Full Text] [Related]
7. Improved IgG3 levels and reduced infection rate in a woman with CVID switched from intravenous to subcutaneous immunoglobulin therapy.
Shapiro RS
Immunotherapy; 2012 Dec; 4(12):1835-9. PubMed ID: 23240751
[TBL] [Abstract][Full Text] [Related]
8. Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients.
Danieli MG; Verga JU; Mezzanotte C; Terrenato I; Svegliati S; Bilo MB; Moroncini G
Front Immunol; 2021; 12():805705. PubMed ID: 35111165
[TBL] [Abstract][Full Text] [Related]
9. Practical aspects of immunoglobulin replacement.
Ballow M
Ann Allergy Asthma Immunol; 2017 Oct; 119(4):299-303. PubMed ID: 28958372
[No Abstract] [Full Text] [Related]
10. Granulomatous Uveitis and Conjunctivitis Due to Common Variable Immune Deficiency: A Case Report.
Carter S; Xie K; Knight D; Minckler D; Kedhar S
Ocul Immunol Inflamm; 2019; 27(7):1124-1126. PubMed ID: 30142001
[No Abstract] [Full Text] [Related]
11. [Subcutaneous gammaglobulin in common variable immunodeficiency. First experience in Spain].
Maroto Hernando M; Soler Palacín P; Martin Nalda N; Oliveras Arenas M; Español Boren T; Figueras Nadal C
An Pediatr (Barc); 2009 Feb; 70(2):111-9. PubMed ID: 19217565
[TBL] [Abstract][Full Text] [Related]
12. Hypercalcemia in a patient with common variable immunodeficiency and renal granulomas.
Meyer A; Lachmann HJ; Webster AD; Burns A; Thway K
Am J Kidney Dis; 2005 May; 45(5):e90-3. PubMed ID: 15861342
[TBL] [Abstract][Full Text] [Related]
13. Sarcoid-like granulomas in common variable immunodeficiency.
Artac H; Bozkurt B; Talim B; Reisli I
Rheumatol Int; 2009 Nov; 30(1):109-12. PubMed ID: 19326121
[TBL] [Abstract][Full Text] [Related]
14. Home therapy with subcutaneous immunoglobulins for patients with primary immunodeficiency diseases.
Haddad É; Barnes D; Kafal A
Transfus Apher Sci; 2012 Jun; 46(3):315-21. PubMed ID: 22503304
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin Replacement Therapy for Primary Immunodeficiency.
Sriaroon P; Ballow M
Immunol Allergy Clin North Am; 2015 Nov; 35(4):713-30. PubMed ID: 26454315
[TBL] [Abstract][Full Text] [Related]
16. Prospective study on CVID patients with adverse reactions to intravenous or subcutaneous IgG administration.
Quinti I; Soresina A; Agostini C; Spadaro G; Matucci A; Sfika I; Martini H; Borghese F; Guerra A; Alessandra V; Visentini M; Plebani A; Fiorilli M
J Clin Immunol; 2008 May; 28(3):263-7. PubMed ID: 18214651
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous granulomas in common variable immunodeficiency: case report and review of literature.
Aghamohammadi A; Abolhassani H; Rezaei N; Kalantari N; Tamizifar B; Cheraghi T; Parvaneh N; Yeganeh M; Moazzami K; Ebrahimi-Daryani N; Anaraki MR
Acta Dermatovenerol Croat; 2010; 18(2):107-13. PubMed ID: 20624361
[TBL] [Abstract][Full Text] [Related]
18. Fatigue and the wear-off effect in adult patients with common variable immunodeficiency.
Hajjar J; Kutac C; Rider NL; Seeborg FO; Scalchunes C; Orange J
Clin Exp Immunol; 2018 Dec; 194(3):327-338. PubMed ID: 30168848
[TBL] [Abstract][Full Text] [Related]
19. Skin Necrosis Following Subcutaneous Immunoglobulin (SCIg).
Carne E; Ponsford M; El-Shanawany T; Jolles S
J Clin Immunol; 2017 Jan; 37(1):27-28. PubMed ID: 27796699
[No Abstract] [Full Text] [Related]
20. Comparison of Diagnostic Criteria for Common Variable Immunodeficiency Disorders (CVID) in the New Zealand CVID Cohort Study.
Ameratunga R; Longhurst H; Steele R; Woon ST
Clin Rev Allergy Immunol; 2021 Oct; 61(2):236-244. PubMed ID: 34236581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
